clinical trial · NCT06825416
A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
Beijing Suncadia Pharmaceuticals Co., Ltd·phase3·completed·n = 1,166
Prevention of Arterial and Venous ThrombosisSHR-2004 injectionSHR-2004 injectionEnoxaparin sodium injectionEnoxaparin sodium injection placeboSHR-2004 placeboSHR-2004 placebo
brief summary
The purpose of the study is to evaluate the efficacy and safety of SHR-2004 in preventing venous thromboembolism after elective unilateral total knee arthroplasty.
started
Mar 16, 2025
primary completion
Feb 15, 2026
completion
Apr 10, 2026
last updated
Apr 13, 2026
official title
A Multicenter, Randomized, Double-blind, Active-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in the Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Arthroplasty
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol